Gary L. Kunz

Array ( [id] => 3998575 [patent_doc_number] => 05858698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Methods for detection of enteropathogenic e. coli' [patent_app_type] => 1 [patent_app_number] => 8/679184 [patent_app_country] => US [patent_app_date] => 1996-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8520 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858698.pdf [firstpage_image] =>[orig_patent_app_number] => 679184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926519 [patent_doc_number] => 05945525 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Method for isolating nucleic acids using silica-coated magnetic particles' [patent_app_type] => 1 [patent_app_number] => 8/676982 [patent_app_country] => US [patent_app_date] => 1996-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7329 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945525.pdf [firstpage_image] =>[orig_patent_app_number] => 676982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876268 [patent_doc_number] => 05824793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Solid phase synthesis of oligonucleotide N3\'-P5\' phosphoramidates' [patent_app_type] => 1 [patent_app_number] => 8/663918 [patent_app_country] => US [patent_app_date] => 1996-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 17923 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824793.pdf [firstpage_image] =>[orig_patent_app_number] => 663918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775033 [patent_doc_number] => 05756711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Phospholipid derivatives of nucleosides and their use as anti-viral medicaments' [patent_app_type] => 1 [patent_app_number] => 8/661038 [patent_app_country] => US [patent_app_date] => 1996-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3722 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756711.pdf [firstpage_image] =>[orig_patent_app_number] => 661038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773274 [patent_doc_number] => 05849906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Antigenic conjugates of polycyclic aromatic hydrocarbons to nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/636856 [patent_app_country] => US [patent_app_date] => 1996-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19494 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849906.pdf [firstpage_image] =>[orig_patent_app_number] => 636856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3746148 [patent_doc_number] => 05716941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Use of methyl donor compounds to treat neurological dysfunction associated with immune defects' [patent_app_type] => 1 [patent_app_number] => 8/623888 [patent_app_country] => US [patent_app_date] => 1996-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4757 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716941.pdf [firstpage_image] =>[orig_patent_app_number] => 623888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771383 [patent_doc_number] => 05756478 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Method for reducing toxicity of D-nucleoside analogs with L-nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/616912 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8295 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756478.pdf [firstpage_image] =>[orig_patent_app_number] => 616912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689207 [patent_doc_number] => 05663323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Synthesis of 4-alkoxy-5-fluoro-2\'-deoxyuridine and its incorporation into oligonocleotides' [patent_app_type] => 1 [patent_app_number] => 8/613582 [patent_app_country] => US [patent_app_date] => 1996-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3998 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663323.pdf [firstpage_image] =>[orig_patent_app_number] => 613582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888800 [patent_doc_number] => 05714597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Use of carbocation scavenger during oligonucleotide synthesis' [patent_app_type] => 1 [patent_app_number] => 8/613036 [patent_app_country] => US [patent_app_date] => 1996-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9713 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714597.pdf [firstpage_image] =>[orig_patent_app_number] => 613036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868351 [patent_doc_number] => 05763208 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Oligonucleotides and their analogs capable of passive cell membrane permeation' [patent_app_type] => 1 [patent_app_number] => 8/608420 [patent_app_country] => US [patent_app_date] => 1996-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13405 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763208.pdf [firstpage_image] =>[orig_patent_app_number] => 608420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4020021 [patent_doc_number] => 05907036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Procedures for obtaining ribo-C-nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/603106 [patent_app_country] => US [patent_app_date] => 1996-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7094 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/907/05907036.pdf [firstpage_image] =>[orig_patent_app_number] => 603106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868171 [patent_doc_number] => 05763196 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Assays using cross-linked polypeptide fragments of .beta.-galactosidase' [patent_app_type] => 1 [patent_app_number] => 8/592029 [patent_app_country] => US [patent_app_date] => 1996-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9438 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763196.pdf [firstpage_image] =>[orig_patent_app_number] => 592029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3845347 [patent_doc_number] => 05708161 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Nucleoside phosphorothioate derivatives, synthesis and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/590280 [patent_app_country] => US [patent_app_date] => 1996-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10988 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/708/05708161.pdf [firstpage_image] =>[orig_patent_app_number] => 590280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886456 [patent_doc_number] => 05723449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Methods and compositions for inhibiting uridine secretion' [patent_app_type] => 1 [patent_app_number] => 8/589017 [patent_app_country] => US [patent_app_date] => 1996-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5454 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723449.pdf [firstpage_image] =>[orig_patent_app_number] => 589017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771370 [patent_doc_number] => 05756477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Treatment of aids with complex of poly (A). poly (U)' [patent_app_type] => 1 [patent_app_number] => 8/582658 [patent_app_country] => US [patent_app_date] => 1996-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2448 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756477.pdf [firstpage_image] =>[orig_patent_app_number] => 582658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787361 [patent_doc_number] => 05736528 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'N.sup.6 -(epoxynorborn-2-yl) adenosines as A.sub.1 adenosine receptor agonists' [patent_app_type] => 1 [patent_app_number] => 8/581655 [patent_app_country] => US [patent_app_date] => 1995-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 14806 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736528.pdf [firstpage_image] =>[orig_patent_app_number] => 581655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664103 [patent_doc_number] => 05625052 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Method for preparing 3\'-nitrogen containing polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/576206 [patent_app_country] => US [patent_app_date] => 1995-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7456 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/625/05625052.pdf [firstpage_image] =>[orig_patent_app_number] => 576206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692115 [patent_doc_number] => 05679532 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Serum ferritin as a predictor of the acute respiratory distress syndrome' [patent_app_type] => 1 [patent_app_number] => 8/571588 [patent_app_country] => US [patent_app_date] => 1995-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9560 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679532.pdf [firstpage_image] =>[orig_patent_app_number] => 571588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190084 [patent_doc_number] => 06153594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => '5\'-O-acylated antiviral nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/532754 [patent_app_country] => US [patent_app_date] => 1995-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 4 [patent_no_of_words] => 7576 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153594.pdf [firstpage_image] =>[orig_patent_app_number] => 532754 [rel_patent_id] =>[rel_patent_doc_number] =>)